Literature DB >> 22507542

Restoration of glucose metabolism in leptin-resistant mouse hearts after acute myocardial infarction through the activation of survival kinase pathways.

William Witham1, Keith Yester, Christopher P O'Donnell, Kenneth R McGaffin.   

Abstract

In the normal heart, leptin modulates cardiac metabolism. It is unknown, however, what effect leptin has on cardiac metabolism and outcomes in acute myocardial infarction (MI). This study was performed to test the hypothesis that leptin signaling increases glucose metabolism and attenuates injury in the acutely infarcted heart. Mice with (ObR(+/+)) and without (ObR(-/-)) cardiomyocyte specific expression of leptin receptor (ObR) were randomly assigned to experimental MI or sham procedure, and studied 3 days later. ObR(+/+) and ObR(-/-) sham mice were not significantly different in any measured outcome. However, after MI, ObR(-/-) mice had greater cardiac dysfunction, left ventricular dilation, and levels of oxidative stress. These worse indices of cardiac injury in ObR(-/-) mice were associated with attenuated signal transducer and activator of transcription (STAT) 3, phosphatidylinositol-3-kinase (PI3K), and Akt signaling, decreased malonyl CoA content, and reduced mitochondrial pyruvate dehydrogenase and electron transport Complex I, II and IV activities. Furthermore, ObR(-/-) mice maintained high rates of cardiac fatty acid oxidation after MI, whereas ObR(+/+) mice demonstrated a switch away from fatty acid oxidation to glucose metabolism. Restoration of cardiac STAT3, PI3K and Akt activity and mitochondrial function in ObR(-/-) mice post-MI was accomplished by ciliary neurotrophic factor (CNTF), an established STAT3 activator, administered immediately after MI. Moreover, CNTF therapy resulted in mitigation of cardiac structural and functional injury, attenuated levels of oxidative stress, and rescued glucose metabolism in the infarcted ObR(-/-) heart. These data demonstrate that impaired cardiac leptin signaling results in metabolic inflexibility for glucose utilization in the face of cardiac stress, and greater morbidity after MI. Further, these studies show that cardiac glucose metabolism can be restored in leptin-resistant hearts by CNTF-mediated activation of survival kinases, resulting in multiple improved structural and functional outcomes post-MI.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22507542     DOI: 10.1016/j.yjmcc.2012.03.016

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  7 in total

1.  Association of serum leptin with future left ventricular structure and function: The Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Shishir Sharma; Laura A Colangelo; Matthew A Allison; Joao A C Lima; Bharath Ambale-Venkatesh; Satoru Kishi; Kiang Liu; Philip Greenland
Journal:  Int J Cardiol       Date:  2015-05-14       Impact factor: 4.164

Review 2.  Lean heart: Role of leptin in cardiac hypertrophy and metabolism.

Authors:  Michael E Hall; Romain Harmancey; David E Stec
Journal:  World J Cardiol       Date:  2015-09-26

3.  Cardiomyocyte-specific deletion of leptin receptors causes lethal heart failure in Cre-recombinase-mediated cardiotoxicity.

Authors:  Michael E Hall; Grant Smith; John E Hall; David E Stec
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-10-31       Impact factor: 3.619

Review 4.  Tissue-Specific Effects of Leptin on Glucose and Lipid Metabolism.

Authors:  Sandra Pereira; Daemon L Cline; Maria M Glavas; Scott D Covey; Timothy J Kieffer
Journal:  Endocr Rev       Date:  2021-01-28       Impact factor: 19.871

5.  RNA SEQ Analysis Indicates that the AE3 Cl-/HCO3- Exchanger Contributes to Active Transport-Mediated CO2 Disposal in Heart.

Authors:  Kanimozhi Vairamani; Hong-Sheng Wang; Mario Medvedovic; John N Lorenz; Gary E Shull
Journal:  Sci Rep       Date:  2017-08-04       Impact factor: 4.379

6.  Leptin increases mitochondrial OPA1 via GSK3-mediated OMA1 ubiquitination to enhance therapeutic effects of mesenchymal stem cell transplantation.

Authors:  Fan Yang; Rongrong Wu; Zhi Jiang; Jinghai Chen; Jinliang Nan; Sheng'an Su; Na Zhang; Chen Wang; Jing Zhao; Cheng Ni; Yingchao Wang; Wangxing Hu; Zhiru Zeng; Keyang Zhu; Xianbao Liu; Xinyang Hu; Wei Zhu; Hong Yu; Jinyu Huang; Jian'an Wang
Journal:  Cell Death Dis       Date:  2018-05-01       Impact factor: 8.469

Review 7.  Role of Leptin in Cardiovascular Diseases.

Authors:  Mareike S Poetsch; Anna Strano; Kaomei Guan
Journal:  Front Endocrinol (Lausanne)       Date:  2020-06-16       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.